Moleculalr assay analyzer
Ended Purchase Order Awarded Last action
- Contract number
- HT940625P0027
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,538,009
Award facts
- Contract value 100% obligated
- $1,538,009.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Camp Pendleton North, CA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $769,005 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $769,005 |
About this award
The Defense Health Agency awarded a $1.54M firm fixed-price purchase order to Biofire Defense LLC on April 15, 2025, for the procurement of a molecular assay analyzer with an ultimate completion date of April 14, 2026. The equipment will be delivered to Camp Pendleton North, California. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001. This award utilizes no set-aside designation, reflecting the company's competitive positioning as a specialized biodefense vendor. The molecular assay analyzer aligns with the Defense Health Agency's broader mission to support infectious disease detection and biodefense capabilities across the Department of Defense medical treatment facilities.
This purchase order represents one component of Biofire Defense's extensive federal contract portfolio supporting biodefense and public health preparedness missions. The company maintains multiple indefinite delivery vehicles with the Defense Health Agency, National Institutes of Health, and Department of State, collectively valued at over $14M, which procure diagnostic equipment, reagents, and related services. These agreements enable flexible, pre-negotiated procurement of Biofire's FilmArray and RAZOR Mk II diagnostic systems and associated consumables across multiple federal agencies, supporting the government's strategic capability to rapidly identify infectious disease threats and biological agents in military and civilian medical settings.
Quick answers
Who was awarded contract HT940625P0027?
HT940625P0027 was awarded to Biofire Defense LLC by Defense Health Agency (Department of Defense) on April 15, 2025.
How much is contract HT940625P0027 worth?
The government has obligated $1,538,009 on HT940625P0027.
Was contract HT940625P0027 competed?
The extent of competition for HT940625P0027 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award